Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Overall Survival of FOLFOX6m Plus SIR-Spheres Microspheres Versus FOLFOX6m Alone as First-line Treatment in Patients With Non-resectable Liver Metastases From Primary Colorectal Carcinoma in a Randomised Clinical Study

NCT01721954 is registered in ClinicalTrials.gov with Sirtex Medical as lead sponsor.

NCT NCT01721954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01721954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Overall Survival of FOLFOX6m Plus SIR-Spheres Microspheres Versus FOLFOX6m Alone as First-line Treatment in Patients With Non-resectable Liver Metastases From Primary Colorectal Carcinoma in a Randomised Clinical Study
Lead sponsor
Sirtex Medical
Phase
Phase 3
Overall status
Completed
Start date
May 1, 2013
Completion date
February 28, 2017
Enrollment
209 (actual)
Sites
83

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic